The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
Schott, Gisela
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. [electronic resource] - Deutsches Arzteblatt international Apr 2010 - 279-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1866-0452
10.3238/arztebl.2010.0279 doi
Clinical Trials as Topic--economics
Conflict of Interest--economics
Drug Industry--economics
Ethics, Pharmacy
Germany
Humans
Publication Bias
Research Support as Topic--economics
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. [electronic resource] - Deutsches Arzteblatt international Apr 2010 - 279-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1866-0452
10.3238/arztebl.2010.0279 doi
Clinical Trials as Topic--economics
Conflict of Interest--economics
Drug Industry--economics
Ethics, Pharmacy
Germany
Humans
Publication Bias
Research Support as Topic--economics